Details of the Drug

General Information of Drug (ID: DMK2Y4V)

Drug Name

Ancrod

Synonyms

Arvin; Arwin; Venacil; Viprinex; Agkistrodon rhodostoma venom proteinase; Agkistrodon serine proteinase; Snake venom, Knoll

Indication

Disease Entry	ICD 11	Status	REF
Blood forming organ disorder	JB64.1	Phase 3	[1]
------------------------------------------------------------------------------------

ATC Code

B01AD09: Ancrod

B01AD: Enzymes

B01A: ANTITHROMBOTIC AGENTS

B01: ANTITHROMBOTIC AGENTS

B: BLOOD AND BLOOD FORMING ORGANS

ADMET Property

Absorption: The absorption of drug is 100% []
Half-life: The concentration or amount of drug in body reduced by one-half in 3 - 5 hours [2]

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Vitamin K-dependent protein C (PROC)	TTZUXYS	PROC_HUMAN	Modulator	[3]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT00141011) Ancrod (Viprinex for the Treatment of Acute, Ischemic Stroke. U.S. National Institutes of Health.
2	Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 1352 Drug Compounds
3	Ancrod (Arvin) as an alternative to heparin anticoagulation for cardiopulmonary bypass. Anesthesiology. 1989 Dec;71(6):870-7.